Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction

Sally Lee, Daniel Glicklich, Maria Coco

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint Dive into the research topics of 'Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction'. Together they form a unique fingerprint.

Medicine & Life Sciences